Clinical Trials Logo

Clinical Trial Summary

This study was aimed to reveal the clinical features,natural history of the diseases and current therapeutic situations of cerebral venous thrombosis (CVT) in China mainland. Blood samples and cerebrospinal fluid samples will be collected after recruitment to reveal the pathological mechanisms of CVT and identify the biomarkers for CVT.


Clinical Trial Description

cerebral venous thrombosis (CVT) is caused by a clot in the cerebral vein, which resulted in an obstruction of the blood outflow. CVT mainly includes cerebral venous sinus thrombosis, deep cerebral vein thrombosis and cortical vein thrombosis. However, the epidemiological features of CVT in China mainland remained obscure. This study was aimed to establish a multicenter cohort recruiting patients with CVT across 31 provinces and municipalities in China mainland. Clinical features,natural history of the diseases and current therapeutic situations will be analyzed to reveal the epidemiological features of CVT. Blood samples and cerebrospinal fluid samples will be collected after recruitment to reveal the pathological mechanisms of CVT and identify the biomarkers for CVT. Patients will be followed-up at 1, 3, 6, 12 months from baseline to evaluate the clinical prognosis and therapeutic outcomes. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03919305
Study type Observational
Source Capital Medical University
Contact Min Li, MD, PhD
Phone +86-18701519698
Email 812879698@qq.com
Status Not yet recruiting
Phase
Start date June 1, 2019
Completion date May 31, 2029

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04269954 - The Efficacy and Safety of Batroxobin Combined With Anticoagulation in Cerebral Venous Sinus Thrombosis Phase 4
Recruiting NCT03273179 - Cerebral Venous Sinus Thrombosis: Re-exploration of Clinical Assessment Scales N/A
Recruiting NCT05291585 - The Dedicated Venous Sinus Thrombectomy Stent for Endovascular Treatment of Cerebral Venous Sinus Thrombosis. N/A
Recruiting NCT04966182 - Application CT and MRI in Cerebral Venous Sinus Thrombosis
Recruiting NCT05021198 - The Norwegian Cerebral Venous Thrombosis Study
Withdrawn NCT04580238 - Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache Phase 1
Completed NCT05448248 - Multicenter Registry Study Of Cerebral Venous Thrombosis In China (RETAIN-CH)